It was reported that this cardiac resynchronization therapy defibrillator (crt-d) dropped its longevity from 10.5 to 7.5 years in a span of 8 months.Boston scientific technical services (ts) reviewed and explained there was no changes made with the device programming and no atrial fibrillation (af).Moreover, it was noted that this device has delivered anti-tachycardia pacing (atp) two months ago and a capacitor reform was done, but this would have expected device to have recovered by now.A request was made to have data from this device analyzed.Data analysis confirmed device depleting normally and that the power consumption has increased in the beginning of this month due to a significant increase in heart rate.Additionally.The patient with this device had infection.This device was explanted and replaced.No additional adverse patient effects were reported.
|